Diselenide–Pemetrexed Assemblies for Combined Cancer Immuno‐, Radio‐, and Chemotherapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diselenide–Pemetrexed Assemblies for Combined Cancer Immuno‐, Radio‐, and Chemotherapies

Published:2020-02-10 Issue:7 Volume:59 Page:2700-2704
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Li Tianyu¹,Pan Shuojiong¹,Gao Shiqian¹,Xiang Wentian¹,Sun Chenxing¹,Cao Wei²,Xu Huaping¹^ORCID

Affiliation:

1. Key Lab of Organic Optoelectronics & Molecular EngineeringDepartment of ChemistryTsinghua University Beijing 100084 P. R. China

2. Department of ChemistryNorthwestern University 2145 Sheridan Road Evanston IL 60208 USA

Funder

National Basic Research Program of China

China National Funds for Distinguished Young Scientists

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.201914453

Reference64 articles.

1.

2. The blockade of immune checkpoints in cancer immunotherapy

3. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy

4. Durch Nanopartikel vermittelter immunogener Zelltod ermöglicht und verstärkt die Immuntherapie gegen Krebs

5.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS-sensitive PD-L1 siRNA cationic selenide nanogels for self-inhibition of autophagy and prevention of immune escape;Bioactive Materials;2024-11

2. Colorectal cancer treatment strategy: Targeting O-GlcNAcylation of Yes-associated protein utilizing diselenide-bridged nanovesicles;Chemical Engineering Journal;2024-10

3. Harnessing transcription factor-driven ROS for synergistic multimodal lung cancer treatment;Journal of Controlled Release;2024-10

4. Biosynthetic MnSe nanobomb with low Mn content activates the cGAS-STING pathway and induces immunogenic cell death to enhance antitumour immunity;Acta Biomaterialia;2024-08

5. Natural Killer-Based Therapy: A Prospective Thought for Cancer Treatment Related to Diversified Drug Delivery Pathways;Pharmaceutics;2024-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3